AAAAAA

   
Results: 1-20 |
Results: 20
ALPHA-INTERFERON THERAPY IN DANISH HEMOPHILIAC PATIENTS WITH CHRONIC HEPATITIS-C - RESULTS OF A RANDOMIZED CONTROLLED OPEN-LABEL STUDY COMPARING 2 DIFFERENT MAINTENANCE REGIMENS FOLLOWING STANDARD INTERFERON-ALPHA-2B TREATMENT
Authors: LAURSEN AL SCHEIBEL E INGERSLEV J CLAUSEN NC WANTZIN P OSTERGAARD L SCHOU G BLACK FT KROGSGAARD K
Citation: Al. Laursen et al., ALPHA-INTERFERON THERAPY IN DANISH HEMOPHILIAC PATIENTS WITH CHRONIC HEPATITIS-C - RESULTS OF A RANDOMIZED CONTROLLED OPEN-LABEL STUDY COMPARING 2 DIFFERENT MAINTENANCE REGIMENS FOLLOWING STANDARD INTERFERON-ALPHA-2B TREATMENT, Haemophilia, 4(1), 1998, pp. 25-32
OUTPATIENTS KNOWLEDGE ABOUT AND ATTITUDE TOWARDS CLINICAL RESEARCH AND RANDOMIZED CLINICAL-TRIALS
Authors: KJAERGAARD LL KRUSE AY KROGSGAARD K GLUUD NC MORTENSEN EL GOTTSCHAU A BJERG AM
Citation: Ll. Kjaergaard et al., OUTPATIENTS KNOWLEDGE ABOUT AND ATTITUDE TOWARDS CLINICAL RESEARCH AND RANDOMIZED CLINICAL-TRIALS, Danish medical bulletin, 45(4), 1998, pp. 439-443
THE IMPACT OF WRITTEN INFORMATION ON OUTPATIENTS KNOWLEDGE ABOUT AND ATTITUDE TOWARDS RANDOMIZED CLINICAL-TRIALS
Authors: KRUSE AY KJAERGAARD LL KROGSGAARD K GLUUD C MORTENSEN EL GOTTSCHAU A
Citation: Ay. Kruse et al., THE IMPACT OF WRITTEN INFORMATION ON OUTPATIENTS KNOWLEDGE ABOUT AND ATTITUDE TOWARDS RANDOMIZED CLINICAL-TRIALS, Zhongguo yaoli xuebao, 19, 1998, pp. 23-23
DELAYED CLEARANCE OF SERUM HBSAG IN COMPENSATED CIRRHOSIS-B - RELATION TO INTERFERON-ALPHA THERAPY AND DISEASE PROGNOSIS
Authors: FATTOVICH G GIUSTINA G SANCHEZTAPIAS J QUERO C MAS A OLIVOTTO PG SOLINAS A ALMASIO P HADZIYANNIS S DEGOS F DEMOURA MC KROGSGAARD K PANTALENA M REALDI G CORROCHER R SCHALM SW CRAXI A DELAROCQUE E SAVVAS S COSSU PA TOCCO A OLSEN JF CHRISTENSEN E ROCHA P
Citation: G. Fattovich et al., DELAYED CLEARANCE OF SERUM HBSAG IN COMPENSATED CIRRHOSIS-B - RELATION TO INTERFERON-ALPHA THERAPY AND DISEASE PROGNOSIS, The American journal of gastroenterology, 93(6), 1998, pp. 896-900
LONG-TERM OUTCOME OF HEPATITIS-B E-ANTIGEN-POSITIVE PATIENTS WITH COMPENSATED CIRRHOSIS TREATED WITH INTERFERON-ALFA
Authors: FATTOVICH G GIUSTINA G REALDI G CORROCHER R SCHALM SW ALMASIO P DEGOS F OLIVOTTO PG SANCHEZTAPIAS J HADZIYANNIS S SOLINAS A KROGSGAARD K DEMOURA MC
Citation: G. Fattovich et al., LONG-TERM OUTCOME OF HEPATITIS-B E-ANTIGEN-POSITIVE PATIENTS WITH COMPENSATED CIRRHOSIS TREATED WITH INTERFERON-ALFA, Hepatology, 26(5), 1997, pp. 1338-1342
WOULD YOU TRUST A SURROGATE RESPONDENT
Authors: GLUUD C KROGSGAARD K
Citation: C. Gluud et K. Krogsgaard, WOULD YOU TRUST A SURROGATE RESPONDENT, Lancet, 349(9053), 1997, pp. 665-666
DELAYED LOSS OF SERUM HBSAG IN CIRRHOSIS TYPE-B - RELATIONSHIP TO INTERFERON-ALFA THERAPY AND DISEASE PROGNOSIS
Authors: GIUSTINA G FATTOVICH G SANCHEZTAPIAS J QUERO C MAS A OLIVOTTO P SOLINAS A ALMASIO P HADZIYANNIS S DEGOS F DEMOURA MC KROGSGAARD K REALDI G SCHALM SW
Citation: G. Giustina et al., DELAYED LOSS OF SERUM HBSAG IN CIRRHOSIS TYPE-B - RELATIONSHIP TO INTERFERON-ALFA THERAPY AND DISEASE PROGNOSIS, Hepatology, 24(4), 1996, pp. 607-607
MOLECULAR STUDY OF GBV-C IN DIALYSIS PATIENTS
Authors: BUKH J WANTZIN P KROGSGAARD K APGAR C KNUDSEN F PURCELL RH
Citation: J. Bukh et al., MOLECULAR STUDY OF GBV-C IN DIALYSIS PATIENTS, Hepatology, 24(4), 1996, pp. 645-645
RELATION BETWEEN TREATMENT EFFICACY AND CUMULATIVE DOSE OF ALPHA-INTERFERON IN CHRONIC HEPATITIS-B
Authors: KROGSGAARD K CHRISTENSEN E BINDSLEV N SCHALM S ANDERSEN PK RINGLARSEN H CARRENO V CRAXI A GERKEN G SCHLICHTING P THOMAS HC TREPO C
Citation: K. Krogsgaard et al., RELATION BETWEEN TREATMENT EFFICACY AND CUMULATIVE DOSE OF ALPHA-INTERFERON IN CHRONIC HEPATITIS-B, Journal of hepatology, 25(6), 1996, pp. 795-802
PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B
Authors: KROGSGAARD K MARCELLIN P TREPO C BERTHELOT P SANCHEZTAPIAS JM BASSENDINE M TRAN A OUZAN D RINGLARSEN H LINDBERG J ENRIQUEZ J BENHAMOU JP BINDSLEV N BERTET S BOYER N BRIND A CIVEIRA MP HOUSSET C LUNDLAURSEN A MAS A POL S PRIETO J QUEDENS J RAMPAL P SCHLICHTING P SORIANO G SPACEY BEM HAWLEY S BRAND C HOWE I
Citation: K. Krogsgaard et al., PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B, Journal of hepatology, 25(6), 1996, pp. 803-813
OCCURRENCE OF HEPATOCELLULAR-CARCINOMA AND DECOMPENSATION IN WESTERN-EUROPEAN PATIENTS WITH CIRRHOSIS TYPE-B
Authors: FATTOVICH G GIUSTINA G SCHALM SW HADZIYANNIS S SANCHEZTAPIAS J ALMASIO P CHRISTENSEN E KROGSGAARD K DEGOS F DEMOURA MC SOLINAS A NOVENTA F REALDI G ALBERTI A QUERO C SAVVAS S MAS A CRAXI A OLSEN JF DELAROCQUE E ROCHA P TOCCO A COSSU PA
Citation: G. Fattovich et al., OCCURRENCE OF HEPATOCELLULAR-CARCINOMA AND DECOMPENSATION IN WESTERN-EUROPEAN PATIENTS WITH CIRRHOSIS TYPE-B, Hepatology, 21(1), 1995, pp. 77-82
VOIDING PROBLEMS IN PATIENTS WITH HIV-INFECTION AND AIDS
Authors: GYRTRUP HJ KRISTIANSEN VB ZACHARIAE CO KROGSGAARD K COLSTRUP H JENSEN KME
Citation: Hj. Gyrtrup et al., VOIDING PROBLEMS IN PATIENTS WITH HIV-INFECTION AND AIDS, Scandinavian journal of urology and nephrology, 29(3), 1995, pp. 295-298
PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B
Authors: KROGSGAARD K MARCELLIN P TREPO C",BERTHELOT,"SANCHEZTAPIAS J BASSENDINE M RAMPAL DO RINGLARSEN H LINDBERG J ENRIQUEZ J BENHAMOU JP BINDSLEV N
Citation: K. Krogsgaard et al., PREDNISOLONE WITHDRAWAL THERAPY ENHANCES THE EFFECT OF HUMAN LYMPHOBLASTOID INTERFERON IN CHRONIC HEPATITIS-B, Hepatology, 19(4), 1994, pp. 90000086-90000086
THE TREATMENT EFFECT OF ALPHA-INTERFERON IN CHRONIC HEPATITIS-B IS INDEPENDENT OF PRETREATMENT VARIABLES - RESULTS BASED ON INDIVIDUAL PATIENT DATA FROM 10 CLINICAL CONTROLLED TRIALS
Authors: KROGSGAARD K BINDSLEV N CHRISTENSEN E CRAXI A SCHLICHTING P SCHALM S CARRENO V TREPO C GERKEN G THOMAS HC ANDERSEN PK RINGLARSEN H
Citation: K. Krogsgaard et al., THE TREATMENT EFFECT OF ALPHA-INTERFERON IN CHRONIC HEPATITIS-B IS INDEPENDENT OF PRETREATMENT VARIABLES - RESULTS BASED ON INDIVIDUAL PATIENT DATA FROM 10 CLINICAL CONTROLLED TRIALS, Journal of hepatology, 21(4), 1994, pp. 646-655
DOES CORTICOSTEROID PRETREATMENT ENHANCE THE EFFECT OF ALFA INTERFERON TREATMENT IN CHRONIC HEPATITIS-B
Authors: KROGSGAARD K
Citation: K. Krogsgaard, DOES CORTICOSTEROID PRETREATMENT ENHANCE THE EFFECT OF ALFA INTERFERON TREATMENT IN CHRONIC HEPATITIS-B, Journal of hepatology, 20(2), 1994, pp. 159-162
CYTOMEGALOVIRUS-INFECTION RATE AMONG HEART-TRANSPLANT PATIENTS IN RELATION TO THE POTENCY OF ANTITHYMOCYTE IMMUNOGLOBULIN INDUCTION THERAPY
Authors: KROGSGAARD K BOESGAARD S ALDERSHVILE J ARENDRUP H MORTENSEN SA PETTERSON G
Citation: K. Krogsgaard et al., CYTOMEGALOVIRUS-INFECTION RATE AMONG HEART-TRANSPLANT PATIENTS IN RELATION TO THE POTENCY OF ANTITHYMOCYTE IMMUNOGLOBULIN INDUCTION THERAPY, Transplantation proceedings, 26(3), 1994, pp. 1718-1718
CYTOMEGALOVIRUS-INFECTION RATE AMONG HEART-TRANSPLANT PATIENTS IN RELATION TO ANTI-THYMOCYTE IMMUNOGLOBULIN INDUCTION THERAPY
Authors: KROGSGAARD K BOESGAARD S ALDERSHVILE J ARENDRUP H MORTENSEN SA PETTERSON G
Citation: K. Krogsgaard et al., CYTOMEGALOVIRUS-INFECTION RATE AMONG HEART-TRANSPLANT PATIENTS IN RELATION TO ANTI-THYMOCYTE IMMUNOGLOBULIN INDUCTION THERAPY, Scandinavian journal of infectious diseases, 26(3), 1994, pp. 239-247
HTLV-I AND HTLV-II IN INTRAVENOUS-DRUG-USERS FROM SWEDEN AND DENMARK
Authors: BLOMBERG J MOESTRUP T FRIMAND J HANSSON BG KROGSGAARD K GRILLNER L NORDENFELT E
Citation: J. Blomberg et al., HTLV-I AND HTLV-II IN INTRAVENOUS-DRUG-USERS FROM SWEDEN AND DENMARK, Scandinavian journal of infectious diseases, 26(1), 1994, pp. 23-26
HEPATITIS-C IN DIALYSIS PATIENTS - RELATIONSHIP TO BLOOD-TRANSFUSIONS, DIALYSIS AND LIVER-DISEASE
Authors: KNUDSEN F WANTZIN P RASMUSSEN K LADEFOGED SD LOKKEGAARD N RASMUSSEN LS LASSEN A KROGSGAARD K
Citation: F. Knudsen et al., HEPATITIS-C IN DIALYSIS PATIENTS - RELATIONSHIP TO BLOOD-TRANSFUSIONS, DIALYSIS AND LIVER-DISEASE, Kidney international, 43(6), 1993, pp. 1353-1356
HIGH PREVALENCE OF HEPATITIS-C VIRUS (HCV) RNA IN DIALYSIS PATIENTS -FAILURE OF COMMERCIALLY AVAILABLE ANTIBODY TESTS TO IDENTIFY A SIGNIFICANT NUMBER OF PATIENTS WITH HCV INFECTION
Authors: BUKH J WANTZIN P KROGSGAARD K KNUDSEN F PURCELL RH MILLER RH
Citation: J. Bukh et al., HIGH PREVALENCE OF HEPATITIS-C VIRUS (HCV) RNA IN DIALYSIS PATIENTS -FAILURE OF COMMERCIALLY AVAILABLE ANTIBODY TESTS TO IDENTIFY A SIGNIFICANT NUMBER OF PATIENTS WITH HCV INFECTION, The Journal of infectious diseases, 168(6), 1993, pp. 1343-1348
Risultati: 1-20 |